Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL25432425 | 0.96 | ALDH1A1 (0.47) | ALDH1A1HSD17B10TSHRTDP1MEN1 | |
| Ether SCHEMBL11575108 | 0.96 | ALDH1A1 (0.40) | ALDH1A1HSD17B10TSHRTDP1MEN1 | |
| SCHEMBL2473861 | 0.92 | ALDH1A1 (0.50) | ALDH1A1HSD17B10TSHRTDP1MEN1 | |
| Ether SCHEMBL1702514 | 0.92 | ALDH1A1 (0.50) | ALDH1A1HSD17B10TSHRTDP1THRB | |
| SCHEMBL273877 | 0.89 | ALDH1A1 (0.47) | ALDH1A1HSD17B10TSHRTDP1MEN1 | |
| SCHEMBL11970063 | 0.89 | ALDH1A1 (0.47) | ALDH1A1HSD17B10TSHRTDP1MEN1 | |
| SCHEMBL394975 | 0.89 | — | — | |
| SCHEMBL272689 | 0.89 | ALDH1A1 (0.47) | ALDH1A1HSD17B10TSHRTDP1MEN1 | |
| SCHEMBL11970056 | 0.89 | ALDH1A1 (0.47) | ALDH1A1HSD17B10TSHRTDP1MEN1 | |
| SCHEMBL12680272 | 0.89 | ALDH1A1 (0.47) | ALDH1A1HSD17B10TSHRTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105304882-A | Preparation method of lithium-sulfur battery cathode material, lithium-sulfur battery cathode material and battery | CHINESE ACAD PHYSICS INST | 2016-02-03 | — | — | CN | claimed |
| EP-0996430-B1 | NUCLEOTIDE ANALOG COMPOSITIONS | GILEAD SCIENCES INC (US) | 2002-11-27 | — | — | EP | claimed |
| US-6451340-B1 | CRYSTALLINE ADEFOVIR DIPIVOXIL | GILEAD SCIENCES, INC. | 2002-09-17 | — | — | US | claimed |
| US-20020045599-A1 | Nucleotide analog compositions | GILEAD SCIENCES, INC. | 2002-04-18 | — | — | US | claimed |
| EP-0996430-A2 | NUCLEOTIDE ANALOG COMPOSITIONS | GILEAD SCIENCES, INC. (US) | 2000-05-03 | — | — | EP | claimed |
| WO-1999004774-A2 | NUCLEOTIDE ANALOG COMPOSITIONS | GILEAD SCIENCES, INC. (US) | 1999-02-04 | — | — | WO | claimed |
| CN-106946748-B | Deliver method, compound, composition and the carrier of 3-APS | BHI有限合资公司 | 2019-02-05 | — | — | CN | disclosed |
| CN-108199021-A | A kind of lithium ion battery big crystal grain body tertiary cathode material and preparation method thereof | 青海泰丰先行锂能科技有限公司 | 2018-06-22 | — | — | CN | disclosed |
| CN-106946748-A | Deliver method, compound, composition and the carrier of the propane sulfonic acid of 3 amino 1 | BHI有限合资公司 | 2017-07-14 | — | — | CN | disclosed |
| CN-101802180-B | Fungal peroxygenases and methods of use | 诺维信公司 | 2017-04-05 | — | — | CN | disclosed |
| CN-106475521-A | A kind of metal casting part preparation method based on 3D printing technique | 苏州聚复高分子材料有限公司 | 2017-03-08 | — | — | CN | disclosed |
| CN-105304882-A | Preparation method of lithium-sulfur battery cathode material, lithium-sulfur battery cathode material and battery | CHINESE ACAD PHYSICS INST | 2016-02-03 | — | — | CN | disclosed |
| WO-2016011630-A1 | PROCESS FOR PREPARING BRANCHED ALLYL COMPOUNDS | SOUTH UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) | 2016-01-28 | — | — | WO | disclosed |
| US-6451340-B1 | CRYSTALLINE ADEFOVIR DIPIVOXIL | GILEAD SCIENCES, INC. | 2002-09-17 | — | — | US | disclosed |
| US-20020045599-A1 | Nucleotide analog compositions | GILEAD SCIENCES, INC. | 2002-04-18 | — | — | US | disclosed |
| EP-0604961-A2 | Method of producing tetrakis(pentafluorophenyl)borate derivatives using pentafluorophenylmagnesium derivatives | TOSOH AKZO CORPORATION (JP) | 1994-07-06 | — | — | EP | disclosed |
| CN-1011287-B | oral hygiene preparation | ICI AMERICA INC (US) | 1991-01-23 | — | — | CN | disclosed |
| CN-85109119-A | ORAL HYGIENE COMPOSITION | — | 1986-08-27 | — | — | CN | disclosed |
| US-4450149-A | REASCTING AN ORGANIC BORANE WITH A RADIOACTIVE HALOMONOCHLORIDE AND A MILD OXIDIZER; RADIOLOGY | RESEARCH CORPORATION (US) | 1984-05-22 | — | — | US | disclosed |
| EP-0099026-A2 | Process for preparing solid titanium trichloride useful for the polymerization of an alpha-olefin | MITSUBISHI KASEI CORPORATION (JP) | 1984-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020045599-A1 | Nucleotide analog compositions | NUDT1, PNP, TYMP | ALDH1A1 2736/4885HSD17B10 2848/4885TSHR 4705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.